Definium Therapeutics (DFTX) Interest & Investment Income (2023 - 2026)

Definium Therapeutics (DFTX) has 4 years of Interest & Investment Income data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Interest & Investment Income rose 42.09% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $12.0 million, a 2.85% decrease from a year earlier, with the FY2025 full-year figure at $11.0 million, down 5.17% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $3.5 million, down from $3.5 million in the prior quarter.
• Over the last five years, Interest & Investment Income for DFTX reached as high as $3.5 million in Q3 2024 and fell as low as $1.3 million in Q4 2023.
• Historically, Interest & Investment Income has averaged $2.4 million across 4 years, with a median of $2.4 million in 2025.
• Across the five-year window, Interest & Investment Income soared 143.97% in 2024 and plunged 35.5% in 2025, its largest moves.
• Year by year, Interest & Investment Income stood at $1.3 million in 2023, then surged by 143.97% to $3.3 million in 2024, then gained by 6.47% to $3.5 million in 2025, then declined by 0.97% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $3.5 million in Q1 2026, $3.5 million in Q4 2025, and $2.3 million in Q3 2025.